Clover Health Investments (CLOV) Liabilities and Shareholders Equity (2019 - 2026)

Clover Health Investments' Liabilities and Shareholders Equity history runs 8 years deep, the most recent figure standing at $697.7 million for Q1 2026.

• Quarterly Liabilities and Shareholders Equity rose 19.53% year-over-year to $697.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.4 billion (up 17.09% YoY) and the FY2025 annual result came in at $541.0 million, down 6.84% from the prior year.
• Liabilities and Shareholders Equity was $697.7 million for Q1 2026 at Clover Health Investments, up from $541.0 million in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.7 billion in Q1 2022 and bottomed at $354.7 million in Q4 2022.
• A 5-year average of $838.2 million and a median of $580.7 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 209.12% — and 2023, when it sank 72.48%.
• Clover Health Investments' Liabilities and Shareholders Equity stood at $354.7 million in 2022, then soared by 60.87% to $570.7 million in 2023, then grew by 1.76% to $580.7 million in 2024, then decreased by 6.84% to $541.0 million in 2025, then increased by 28.97% to $697.7 million in 2026.
• Business Quant data shows CLOV's Liabilities and Shareholders Equity at $697.7 million in Q1 2026, $541.0 million in Q4 2025, and $559.7 million in Q3 2025.